Celltrion Pharm, Inc. (KOSDAQ:068760)
68,100
-1,600 (-2.30%)
At close: Feb 6, 2026
32.06% (1Y)
| Market Cap | 3.02T +22.1% |
| Revenue (ttm) | 274.73B +53.2% |
| Net Income | 26.03B +146.8% |
| EPS | 583.36 +146.0% |
| Shares Out | 44.37M |
| PE Ratio | 116.74 |
| Forward PE | n/a |
| Dividend | 200.00 (0.29%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 168,817 |
| Average Volume | 255,141 |
| Open | 68,100 |
| Previous Close | 69,700 |
| Day's Range | 66,300 - 69,400 |
| 52-Week Range | 43,627 - 76,200 |
| Beta | 1.13 |
| RSI | 54.64 |
| Earnings Date | n/a |